1,026 results on '"Connors, Joseph M."'
Search Results
2. Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population
3. Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approach
4. Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma
5. A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome
6. FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy
7. Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma
8. Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin–specific clinical impact
9. Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy
10. Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL
11. Cell of origin of transformed follicular lymphoma
12. Risk assessment in the management of newly diagnosed classical Hodgkin lymphoma
13. Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma
14. An RCOR1 loss–associated gene expression signature identifies a prognostically significant DLBCL subgroup
15. Long-Term Outcomes of High-Risk Stage 1/2 Classic Hodgkin Lymphoma Managed with an Advanced Stage Treatment Approach
16. Molecular Determinants of Clinical Outcomes In a Real-World Diffuse Large B-cell Lymphoma Population
17. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma
18. Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma
19. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
20. Analysis of FOXO1 mutations in diffuse large B-cell lymphoma
21. Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma
22. Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial
23. A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma
24. Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma
25. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project
26. Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome
27. The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation
28. Constrained FL: A Genetically Distinct Subgroup of Follicular Lymphoma with Low Rates of Somatic Hypermutation and a Reduced Propensity for Histologic Transformation
29. Frontline Therapy with Bendamustine-Rituximab (BR) in Patients with Treatment-Naïve Waldenstrom's Macroglobulinemia Confers Similar Long-Term Outcomes to R-CVP in a Real-World Setting: A Population-Based Analysis
30. Population-Wide Introduction of Dose-Adjusted EPOCH-R Is Associated with Improved Outcome of High Grade B-Cell Lymphoma with MYC and BCL2 Rearrangements with Diffuse Large B-Cell Lymphoma Morphology
31. Outcome of Relapsed and Refractory Peripheral T-Cell Lymphoma (PTCL) with Intention for Curative Therapy Incorporating High Dose Chemotherapy and Hematopoietic Stem Cell Transplant (HDC/SCT)
32. Genomic predictors of central nervous system relapse in primary testicular diffuse large B-cell lymphoma
33. MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy
34. Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival
35. Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP
36. Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival
37. Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances
38. Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP
39. Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP
40. ALK− anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project
41. Brentuximab Vedotin with Chemotherapy for Patients with Previously Untreated, Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study
42. Hodgkin Variant of Richter's Transformation (HvRT) Among Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Patients in British Columbia (BC), Canada
43. Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma
44. Hodgkin lymphoma: outsmarting HRS cells
45. The Tumor Associated Antigen PRAME Exhibits Dualistic Functions That Are Targetable in Diffuse Large B-Cell Lymphoma
46. Cardiac Morbidity in Adolescents and Young Adult Survivors of Hodgkin Lymphoma
47. Real-World Characterization of Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) Patients in British Columbia (BC)
48. Rituximab Monotherapy Compared to Observation in Patients with Newly Diagnosed Asymptomatic Advanced Stage Follicular Lymphoma: A Retrospective Population-Based Analysis
49. The Copy Number Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma
50. Impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHC
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.